These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 29516722

  • 1. PEGylated Self-Assembled Nano-Bacitracin A: Probing the Antibacterial Mechanism and Real-Time Tracing of Target Delivery in Vivo.
    Hong W, Zhao Y, Guo Y, Huang C, Qiu P, Zhu J, Chu C, Shi H, Liu M.
    ACS Appl Mater Interfaces; 2018 Apr 04; 10(13):10688-10705. PubMed ID: 29516722
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, construction, and evaluation of self-assembled nano-bacitracin A as an efficient antibacterial agent in vitro and in vivo.
    Hong W, Gao X, Qiu P, Yang J, Qiao M, Shi H, Zhang D, Tian C, Niu S, Liu M.
    Int J Nanomedicine; 2017 Apr 04; 12():4691-4708. PubMed ID: 28721045
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Insights into the antibacterial mechanism of PEGylated nano-bacitracin A against Streptococcus pneumonia: both penicillin-sensitive and penicillin-resistant strains.
    Hong W, Liu L, Zhang Z, Zhao Y, Zhang D, Liu M.
    Int J Nanomedicine; 2018 Apr 04; 13():6297-6309. PubMed ID: 30349251
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bioconjugated nanoparticles for attachment and penetration into pathogenic bacteria.
    Mei L, Lu Z, Zhang W, Wu Z, Zhang X, Wang Y, Luo Y, Li C, Jia Y.
    Biomaterials; 2013 Dec 04; 34(38):10328-37. PubMed ID: 24090838
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PEGylated ofloxacin nanoparticles render strong antibacterial activity against many clinically important human pathogens.
    Marslin G, Revina AM, Khandelwal VK, Balakumar K, Sheeba CJ, Franklin G.
    Colloids Surf B Biointerfaces; 2015 Aug 01; 132():62-70. PubMed ID: 26005932
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Correction to "PEGylated Self-Assembled Nano-Bacitracin A: Probing the Antibacterial Mechanism and Real-Time Tracing of Target Delivery in Vivo".
    Hong W, Zhao Y, Guo Y, Huang C, Qiu P, Zhu J, Chu C, Shi H, Liu M.
    ACS Appl Mater Interfaces; 2019 Feb 20; 11(7):7635. PubMed ID: 30730129
    [No Abstract] [Full Text] [Related]

  • 11. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.
    Feczkó T, Fodor-Kardos A, Sivakumaran M, Haque Shubhra QT.
    Nanomedicine (Lond); 2016 Aug 20; 11(16):2029-34. PubMed ID: 27462975
    [Abstract] [Full Text] [Related]

  • 12. C-terminal mini-PEGylation of a marine peptide N6 had potent antibacterial and anti-inflammatory properties against Escherichia coli and Salmonella strains in vitro and in vivo.
    Li T, Yang N, Teng D, Mao R, Hao Y, Wang X, Wang J.
    BMC Microbiol; 2022 May 12; 22(1):128. PubMed ID: 35549900
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
    Lim SM, Eom HN, Jiang HH, Sohn M, Lee KC.
    J Pharm Sci; 2015 Jan 12; 104(1):72-80. PubMed ID: 25407390
    [Abstract] [Full Text] [Related]

  • 14. Fatty acid conjugated pyridinium cationic amphiphiles as antibacterial agents and self-assembling nano carriers.
    Walvekar P, Gannimani R, Rambharose S, Mocktar C, Govender T.
    Chem Phys Lipids; 2018 Aug 12; 214():1-10. PubMed ID: 29730266
    [Abstract] [Full Text] [Related]

  • 15. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).
    Na DH, DeLuca PP.
    Pharm Res; 2005 May 12; 22(5):736-42. PubMed ID: 15906168
    [Abstract] [Full Text] [Related]

  • 16. Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery.
    Cai H, Liang Z, Huang W, Wen L, Chen G.
    Int J Pharm; 2017 Oct 30; 532(1):55-65. PubMed ID: 28870763
    [Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP, Pabari R, Chen CN, Al Baharna M, Walsh J, Ramtoola Z.
    J Pharm Pharmacol; 2013 Oct 30; 65(10):1473-81. PubMed ID: 24028614
    [Abstract] [Full Text] [Related]

  • 18. Surface Mechanical and Rheological Behaviors of Biocompatible Poly((D,L-lactic acid-ran-glycolic acid)-block-ethylene glycol) (PLGA-PEG) and Poly((D,L-lactic acid-ran-glycolic acid-ran-ε-caprolactone)-block-ethylene glycol) (PLGACL-PEG) Block Copolymers at the Air-Water Interface.
    Kim HC, Lee H, Khetan J, Won YY.
    Langmuir; 2015 Dec 29; 31(51):13821-33. PubMed ID: 26633595
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapy.
    Rojnik M, Kocbek P, Moret F, Compagnin C, Celotti L, Bovis MJ, Woodhams JH, Macrobert AJ, Scheglmann D, Helfrich W, Verkaik MJ, Papini E, Reddi E, Kos J.
    Nanomedicine (Lond); 2012 May 29; 7(5):663-77. PubMed ID: 22630150
    [Abstract] [Full Text] [Related]

  • 20. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F, d'Angelo I, Coletta C, d'Emmanuele di Villa Bianca R, Sorrentino R, Perfetto B, Tufano MA, Miro A, La Rotonda MI, Quaglia F.
    J Control Release; 2012 Jan 10; 157(1):149-59. PubMed ID: 21864595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.